Prediction: Will the SpaceX IPO Reach a $1.75 Trillion Valuation?

SpaceX is reportedly targeting an IPO this summer, with some reports suggesting a $1.75 trillion valuation and a large retail allocation. The article argues a more plausible valuation is closer to $1.5 trillion, citing Morningstar and PitchBook estimates of roughly $1.1 trillion to $1.7 trillion and noting 2025 combined net losses of about $5 billion at the SpaceX/xAI-linked group. While the news is constructive for valuation momentum and investor interest, it remains highly speculative and unlikely to drive broad market impact.

Analysis

The real tradable signal is not the headline valuation itself, but the transfer of mark-to-market from private secondary markets into a public price discovery event. If the IPO is structured with meaningful retail allocation, that broadens the marginal buyer base and likely compresses near-term volatility in the aftermarket, but it also creates a reflexive setup where scarcity and narrative can overpower fundamentals for several sessions or weeks.

Second-order winners are the capital-markets and indexing ecosystem, not just the issuer. A mega-cap IPO at this scale will force passive and quasi-passive vehicles to build exposure quickly if it enters major benchmarks, creating mechanical demand over the following quarter; that tends to support brokers, market-makers, and ETF wrappers more than it benefits the underlying business. For TSLA, the more important effect is signaling: a large re-rate of Musk-associated private assets can lift the “option value” embedded in the ecosystem and temporarily loosen the market’s willingness to underwrite long-dated moonshot capex stories.

The contrarian risk is that the market is anchoring on a narrative valuation range that may already embed the best-case commercialization path. If IPO filing details reveal governance complexity, dual-track capital needs, or a smaller primary raise than expected, the stock can gap down hard even with strong demand because the real float is limited and expectations are stretched. Another underappreciated risk is timing: a summer process leaves several months for macro risk, IPO-market fatigue, or a risk-off tape to reduce appetite for ultra-long-duration assets.

MORN is a subtle beneficiary if the Street leans on its valuation frameworks and private-market comparables for the listing; any increase in coverage, data demand, or valuation methodology usage is incremental upside. But the bigger edge is in positioning around event volatility rather than directional conviction: this is the kind of name where implied volatility, not intrinsic value, may be mispriced ahead of the filing window.

Key Decisions for Investors

• TSLA: tactically add a small long into the IPO filing window, but use it as a 2-6 week trade only; the multiple may re-rate on Musk ecosystem sentiment, with downside capped by existing mega-cap support and upside from narrative spillover.
• Buy a short-dated straddle on TSLA into the June investor event if implied vol remains below realized-event levels; the setup favors gap risk over smooth drift, with the main risk being a muted announcement.
• MORN: small long on a 1-3 month horizon if the market starts leaning harder on private-market valuation comps; this is a secondary beneficiary, but upside can come from data/analytics demand and sentiment toward valuation frameworks.
• Avoid chasing any direct exposure to the IPO proxy at a wide premium once filing terms are public; if the primary raise is smaller than expected, scarcity premium can unwind quickly in the first 48 hours.
• Relative value: long the market-makers/brokers most levered to IPO activity versus a broad market basket for the 1-2 month event window; the key payoff comes from secondary trading volume and underwriting activity, not just first-day performance.